ScreenerHero
MRVMarvell Technology, Inc.
TSX · CA · Healthcare · Drug Manufacturers - General
48.51CAD+7.54%Mkt Cap: 30.93B $P/E: 11.75

Industry Peers

Drug Manufacturers - General
Screen all
vs Drug Manufacturers - General
P/E
Cheaper
P/B
Cheaper
1M Perf
Lower
LLY
Eli Lilly and Company
$1.07TUSDP/E 42.6
JNJ
Johnson & Johnson
$611.36BUSDP/E 29.4
ABBV
AbbVie Inc.
$444.21BUSDP/E 123.9
RO
Roche Holding AG
$308.01BUSDP/E 21.1
MRK
Merck & Co., Inc.
$317.37BUSDP/E 36.2
NOVNEE
Novartis AG
$281.52BUSDP/E 22.5
NOVN
Novartis AG
$275.65BUSDP/E 22.4
AZN
AstraZeneca PLC
$269.91BUSDP/E 28.1
AZN
AstraZeneca PLC
$237.69BUSDP/E 28.0
NOVO-B
Novo Nordisk A/S
$202.85BUSDP/E 11.5
AMGN
Amgen Inc.
$195.44BUSDP/E 25.2
GILD
Gilead Sciences, Inc.
$156.86BUSDP/E 17.2
PFE
Pfizer Inc.
$137.24BUSDP/E 18.4
BMY
Bristol-Myers Squibb Company
$117.66BUSDP/E 16.1
SAN
Sanofi
$97.68BUSDP/E 19.0
GSK
GSK plc
$86.27BUSDP/E 14.0
BAYN
Bayer Aktiengesellschaft
$51.69BUSD
BIIB
Biogen Inc.
$31.90BUSDP/E 23.3
REC
Recordati Industria Chimica e Farmaceutica S.p.A.
$11.35BUSDP/E 22.7
ORNBV
Orion Oyj
$11.02BUSDP/E 19.1
ORNAV
Orion Oyj
$10.98BUSDP/E 19.1
GRF
Grifols, S.A.
$6.60BUSDP/E 14.6
OGN
Organon & Co.
$3.56BUSDP/E 14.6
VIRP
Virbac SA
$3.03BUSDP/E 18.5
SCLX
Scilex Holding Company
$54.86MUSD
MIRA
MIRA Pharmaceuticals, Inc.
$39.77MUSD
ELXR
Elixxer Ltd.
$9.51MUSD
PHOO
Photocure ASA
—
FLXN
Horizon Flexible Income ETF
—P/E 27.2
CELG-RI
Bristol-Myers Squibb Company Ce
—
ROSE
DocMorris AG
—
Indicators:|

Key Statistics

Company
Market Cap30.93B $
Enterprise Value—
Revenue (TTM)—
Gross Profit3.04B $
Net Income (TTM)1.94B $
Revenue/Share—
Last Price48.51 CAD
Fiscal Year End—
MR Quarter—
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)11.75
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.68
EPS (TTM)—
EPS (Forward)—
52W Range
26.0081% of range53.75
52W High53.75 CAD
52W Low26.00 CAD
Profitability
Gross Margin51.02%
Oper. Margin—
EBITDA Margin—
Profit Margin32.58%
ROE18.66%
ROA11.98%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF1.27B $
CapEx (TTM)261.15M $
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.33
Current Ratio—
Quick Ratio—
Book Value/Sh28.91 CAD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.2400 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.875.55M
Float—
Insiders—
Institutions—
Technical
SMA 5039.44 (+23.0%)
SMA 20039.44 (+23.0%)
Beta—
S&P 52W Chg—
Avg Vol (30d)139.44K
Avg Vol (10d)168.83K
Technical Indicators
RSI (14)58.5
MACD2.7458
MACD Signal3.5525
MACD Hist.-0.8068
BB Upper53.20 CAD
BB Middle46.90 CAD
BB Lower40.59 CAD
BB Width26.88%
ATR (14)4.250 CAD
Vol Ratio (20d)0.87x